Av-Gay Yossef 4
4 · Enox Biopharma Inc · Filed Jun 22, 2010
Insider Transaction Report
Form 4
Av-Gay Yossef
DirectorPresident10% Owner
Transactions
- Award
Option (right to buy)
2010-02-01+800,000→ 800,000 total(indirect: ^)Exercise: $0.45Exp: 2020-02-15→ Common Stock (800,000 underlying)
Footnotes (3)
- [F1]Options granted under Memorandum of Agreement (MofA) between Issuer and G.N.E. Biotechnologies Ltd, a company wholly owned by Reporting Person dated Feb 1, 2010. The vesting schedule is (defined terms set forth in MofA): (i) 1/36th option shares (22,222 options shares, and the last month 22,230) vest every month following the date of the MofA; and (ii) All options vest upon a change of control, if the Reporting Person is terminated for other than cause, and if Issuer closes one or more Investment Transactions and/or Commercial Transactions.
- [F2]The options expire 10 years from the date of the MofA.
- [F3]Held through G.N.E. Biotechnologies Ltd., a company wholly owned by the Reporting Person.